Mette Hartlev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mette Hartlev has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Henriette Sinding Aasen
Faculty of Law, University of Bergen, Norway
2 shared publications - Alexandra Ziaka
Biomedical Research Foundation of the Academy of Athens
1 shared publication - Aliuska Duardo-Sánchez
University of the Basque Country (UPV/EHU)
1 shared publication - Anne-Mette Magnussen1 shared publication
- Carla Barbosa
Universidade de Coimbra
1 shared publication - Christine Dalebø Gjerdevik1 shared publication
Latest Publications
- 18 August 2026
- Published by Edward Elgar Publishing
- p. 382-397
The right to health for people living in poverty: a human rights perspective
- 18 August 2026
- Published by Edward Elgar Publishing
- p. 382-397
The right to health for people living in poverty: a human rights perspective
- 13 August 2026
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 33 (4) , 401-405
Governance of AI and Participatory Involvement of “Lived Experiences”
- 13 August 2026
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 33 (4) , 401-405
Governance of AI and Participatory Involvement of “Lived Experiences”
- 4 December 2025
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 32 (5) , 559-578
Health Data-Driven Research — Time for a Stronger Human Rights Governance Structure?
This article is inspired by Herman Nys’s tireless academic insistence on the importance of human rights and fundamental ethical principles in biomedicine. It examines the evolving landscape of data-driven health research in Europe, using a recent Danish case involving large-scale access to electronic health records as a point of departure. The article explores whether existing European regulatory frameworks adequately safeguard the rights and freedoms of data subjects in contemporary research contexts. The article argues that while data-driven research is often justified by public interest, this concept remains underdefined and insufficiently aligned with patients’ and citizens’ expectations. It concludes that current legal instruments may not fully reflect the broader catalogue of human rights at stake, including dignity, integrity, and protection against discrimination. The article calls for a recalibration of safeguards and governance mechanisms, including stronger ethical review and participatory structures, to ensure that health data research respects both individual rights and collective imaginaries of technological development.
- 4 December 2025
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 32 (5) , 559-578
Health Data-Driven Research — Time for a Stronger Human Rights Governance Structure?
This article is inspired by Herman Nys’s tireless academic insistence on the importance of human rights and fundamental ethical principles in biomedicine. It examines the evolving landscape of data-driven health research in Europe, using a recent Danish case involving large-scale access to electronic health records as a point of departure. The article explores whether existing European regulatory frameworks adequately safeguard the rights and freedoms of data subjects in contemporary research contexts. The article argues that while data-driven research is often justified by public interest, this concept remains underdefined and insufficiently aligned with patients’ and citizens’ expectations. It concludes that current legal instruments may not fully reflect the broader catalogue of human rights at stake, including dignity, integrity, and protection against discrimination. The article calls for a recalibration of safeguards and governance mechanisms, including stronger ethical review and participatory structures, to ensure that health data research respects both individual rights and collective imaginaries of technological development.
- 1 October 2024
- Published by Springer Nature
- p. 243-269
Comparative Review of National Regulatory Frameworks in the Context of Secondary Use of Data for Research Across Europe
- 1 October 2024
- Published by Springer Nature
- p. 243-269
Comparative Review of National Regulatory Frameworks in the Context of Secondary Use of Data for Research Across Europe
- Open Access
- 29 January 2022
- Published by Springer Nature in BioSocieties
- Vol. 18 (2) , 282-307
The life and death of confidentiality: a historical analysis of the flows of patient information
Health data can contain sensitive information. People who consult a doctor seek help on issues that matter to them: they typically expect some form of confidentiality. However, the notion and practices of confidentiality have changed dramatically over time. In this article, we trace the history of confidentiality in the Danish healthcare system, which has one of the world’s most integrated patient information infrastructures. Building on an analysis of legal and political documents dating back to the late seventeenth century, we show that confidentiality originated as a social phenomenon that helped build trust in healthcare professionals and gradually developed into an idiom of citizens rights. Lately, confidentiality has given way to more technocratic forms of data protection. As the political, legal and technological reality, which the idea of confidentiality once referred to, has radically changed, we argue that confidentiality has become what Ulrik Beck has called a ‘zombie category’—a notion that lives on even if its content has passed away. If confidentiality has become a zombie concept, we suggest it is time to discuss what may take its place so that patient interests are protected in the current political economy of health data.
- 29 January 2022
- Published by Springer Nature in BioSocieties
- Vol. 18 (2) , 282-307
Open AccessThe life and death of confidentiality: a historical analysis of the flows of patient information
Health data can contain sensitive information. People who consult a doctor seek help on issues that matter to them: they typically expect some form of confidentiality. However, the notion and practices of confidentiality have changed dramatically over time. In this article, we trace the history of confidentiality in the Danish healthcare system, which has one of the world’s most integrated patient information infrastructures. Building on an analysis of legal and political documents dating back to the late seventeenth century, we show that confidentiality originated as a social phenomenon that helped build trust in healthcare professionals and gradually developed into an idiom of citizens rights. Lately, confidentiality has given way to more technocratic forms of data protection. As the political, legal and technological reality, which the idea of confidentiality once referred to, has radically changed, we argue that confidentiality has become what Ulrik Beck has called a ‘zombie category’—a notion that lives on even if its content has passed away. If confidentiality has become a zombie concept, we suggest it is time to discuss what may take its place so that patient interests are protected in the current political economy of health data.
- 5 April 2021
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 28 (2) , 142-164
Health Disparities and New Health Technologies – A Patients’ and Human Rights Perspective
The human right to health requires that everyone should have equal opportunities to enjoy the highest attainable standard of health. In practice, this is hard to achieve, as health is shaped by social determinants. This article explores the impact personalized medicine and use of big data may have on health disparities. New health technologies offer a lot of hope for more individual and better health promotion and care, which potentially could be beneficial for the most deprived. However, there are also concerns that not all population groups will profit equally from this new population-based medicine, and that new digital health technologies will maintain – or even reinforce – existing health disparities. This article suggests using insights from poverty studies combined with a patients’ and human rights-based approach to ensure that the most deprived are not left behind in the application of new health technologies.
- 5 April 2021
- Published by Walter de Gruyter GmbH in European Journal of Health Law
- Vol. 28 (2) , 142-164
Health Disparities and New Health Technologies – A Patients’ and Human Rights Perspective
The human right to health requires that everyone should have equal opportunities to enjoy the highest attainable standard of health. In practice, this is hard to achieve, as health is shaped by social determinants. This article explores the impact personalized medicine and use of big data may have on health disparities. New health technologies offer a lot of hope for more individual and better health promotion and care, which potentially could be beneficial for the most deprived. However, there are also concerns that not all population groups will profit equally from this new population-based medicine, and that new digital health technologies will maintain – or even reinforce – existing health disparities. This article suggests using insights from poverty studies combined with a patients’ and human rights-based approach to ensure that the most deprived are not left behind in the application of new health technologies.
- Open Access
- 6 January 2021
- Published by Springer Nature
- p. 215-226
Balancing of Individual Rights and Research Interests in Danish Biobank Regulation
Denmark offers very good opportunities for biobank research. There is a vast number of well-structured and comprehensive collections of biological material, which in combination with a ‘research generous’ legislation provides an excellent environment for biobank research. However, both the Danish biobank landscape and the regulatory environment is rather complex. In contrast to a number of other countries, there is no specific biobank act in Denmark. Instead, various regulatory regimes interact, which makes it challenging to navigate in the legal landscape. It is also rather non-transparent for the individuals, from whom samples have been collected, what samples are used for, and how they can influence the use of samples for research. With the GDPR and the Danish Data Protection Act it seems that research participants’ rights have been slightly weakened in Danish law. However, it is argued, that the GDPR has the potential to ensure more awareness of research participants right against the societal and scientific interest in research.
- 6 January 2021
- Published by Springer Nature
- p. 215-226
Open AccessBalancing of Individual Rights and Research Interests in Danish Biobank Regulation
Denmark offers very good opportunities for biobank research. There is a vast number of well-structured and comprehensive collections of biological material, which in combination with a ‘research generous’ legislation provides an excellent environment for biobank research. However, both the Danish biobank landscape and the regulatory environment is rather complex. In contrast to a number of other countries, there is no specific biobank act in Denmark. Instead, various regulatory regimes interact, which makes it challenging to navigate in the legal landscape. It is also rather non-transparent for the individuals, from whom samples have been collected, what samples are used for, and how they can influence the use of samples for research. With the GDPR and the Danish Data Protection Act it seems that research participants’ rights have been slightly weakened in Danish law. However, it is argued, that the GDPR has the potential to ensure more awareness of research participants right against the societal and scientific interest in research.
- 1 December 2015
- Published by SAGE Publications in European Journal of Social Security
- Vol. 17 (4) , 409-435
Right to Hospital Care and Prioritisation from a Law and Politics Perspective – The Experiences of Norway and Denmark
As members of the Nordic family of welfare states, both Norway and Denmark are characterised by universal access to health care. Legislation and individual rights have increasingly been used as tools to promote and protect patients' equal access to health care services. At the same time both countries are struggling with increasing health care expenditures, waiting lists and a demand to prioritise health care resources in light of new and expensive treatment options. This calls for political space to adjust prioritisation policies and procedures. The article analyses the regulation of access to hospital care in Norway and Denmark, from a law and politics perspective. We explore similarities and differences between the two countries with respect to the objectives of the regulation and formulation of the right to hospital care, and how the interplay between law and politics – and juridification and politicisation – is expressed and managed in the regulation. We conclude that even though there are differences between the two countries in the extent of juridification, the regulation in both countries still leaves room for continued political governance of issues related to the prior itisation of health care services.
- 1 December 2015
- Published by SAGE Publications in European Journal of Social Security
- Vol. 17 (4) , 409-435
Right to Hospital Care and Prioritisation from a Law and Politics Perspective – The Experiences of Norway and Denmark
As members of the Nordic family of welfare states, both Norway and Denmark are characterised by universal access to health care. Legislation and individual rights have increasingly been used as tools to promote and protect patients' equal access to health care services. At the same time both countries are struggling with increasing health care expenditures, waiting lists and a demand to prioritise health care resources in light of new and expensive treatment options. This calls for political space to adjust prioritisation policies and procedures. The article analyses the regulation of access to hospital care in Norway and Denmark, from a law and politics perspective. We explore similarities and differences between the two countries with respect to the objectives of the regulation and formulation of the right to hospital care, and how the interplay between law and politics – and juridification and politicisation – is expressed and managed in the regulation. We conclude that even though there are differences between the two countries in the extent of juridification, the regulation in both countries still leaves room for continued political governance of issues related to the prior itisation of health care services.
- 1 January 2011
- Published by Springer Nature
- p. 251-264
Banks, Repositories and Registries of Stem Cell Lines: The Challenges to Legal Regulation
- 1 January 2011
- Published by Springer Nature
- p. 251-264
Banks, Repositories and Registries of Stem Cell Lines: The Challenges to Legal Regulation
- 1 June 2010
- Vol. 17 (3) , 279-94
Recent developments in Nordic health law.
The five Nordic countries--Denmark, Finland, Iceland, Norway and Sweden--share a considerable part of their cultural and historical heritage. They have collaborated closely in their development of legislation during most of the 20th century and are also all traditional welfare states, but nevertheless demonstrate a surprising degree of variety in the area of health law. The Nordic Network for Research in Biomedical Law was founded in 2006, with the aim to promote intra-disciplinary collaboration and stimulate comparative Nordic research in this field of law. Exchange of information on recent legal developments has been a recurrent point on the agenda at the Network meetings.
- 1 June 2010
- Vol. 17 (3) , 279-94
Recent developments in Nordic health law.
The five Nordic countries--Denmark, Finland, Iceland, Norway and Sweden--share a considerable part of their cultural and historical heritage. They have collaborated closely in their development of legislation during most of the 20th century and are also all traditional welfare states, but nevertheless demonstrate a surprising degree of variety in the area of health law. The Nordic Network for Research in Biomedical Law was founded in 2006, with the aim to promote intra-disciplinary collaboration and stimulate comparative Nordic research in this field of law. Exchange of information on recent legal developments has been a recurrent point on the agenda at the Network meetings.